Vortioxetine Is A Novel Antidepressant With Multimodal Activity, Which Is Approved To Treat Major Depressive Disorder (Mdd) In Adults. Sun Pharma On Wednesday Said It Has Entered Into An Exclusive Patent Licensing Agreement With Danish-Drugmaker Lundbeck To Market And Distribute Its Own Version Of Antidepressant Medication Vortioxetine In India Under The Brand Name Vortidiftm. The Territory Of The Licensing Agreement Will Only Cover India. Vortioxetine Is A Novel Antidepressant With Multimodal Activity, Which Is Approved To Treat Major Depressive Disorder (Mdd) In Adults. The Product Is Approved In Over 80 Countries, Including The Us, Eu, Canada And Australia.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!